Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)
Titel:
Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)
Auteur:
Kentepozidis, N. Economopoulou, P. Christofyllakis, Ch. Chelis, L. Polyzos, A. Vardakis, N. Koinis, F. Vamvakas, L. Katsaounis, P. Kalbakis, K. Nikolaou, Ch. Georgoulias, V. Kotsakis, A.